[Second-line treatment of malignant lymphomas (author's transl)].
D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D011879:Radiotherapy Dosage
Sekundärtherapien bei rezidivierenden malignen Lymphomen.